22nd Strategic Project & Portfolio Management for Pharma

This exclusive marcus evans conference will be a three-daylong physical/online event wherein the attendees can enjoy networking with one another and hear insights from Bayer, Merck, Janssen/Johnson, Roche, Novartis Institute for Biomedical Research, Leo-Pharmaand many others on key industry topics such as:

•  Assessnew opportunities in drug development
•  Innovate and invent new models for boosting performance and r&d productivity
• Involve data analytics into PPM strategy from research to commercial phases
•  Align R&D and Portfolio Strategy and motivate your organisation to invest in long-term planning and capacity management
• Balance scientific (data-driven) vs. commercial considerations (aspirational) in portfolio prioritization
• Enhance project, program, and portfolio visibility to improve R&D Performance
• Choose the right structure and methodology to support project planning
• Accelerate investment in data sciences for better, more connected R&D insights

This conference is attended by heads, VPs, Senior Managers of Big Pharma, Biotech, Public Institutions/Research Centers:

• Project and/or Portfolio Management
• Project / Strategic Planning
• Project and/or Portfolio Analysis
• Project and/or Portfolio Valuation
• Business/ Corporate/ Strategic Development
• Product Development
• Pipeline Management/ Pipeline Portfolio
• Investment/ Decision Support
• Alliance management / Business Development

Attend the event and benefit from the networking opportunities while participating in interactive case studies explaining the best methods for controlling your project portfolio.

For more info and available attendance discounts, contact Mr. Ayis Panayi at ayisp@marcusevanscy.com or visit https://bit.ly/3qdC4Nq. Looking forward to welcoming you to the event.